Blueprint Medicines Corp (BPMC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BPMC.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 13 | $152 | $81 | $119.69 | $84.74 | 41.24% |
The Trend in the Analyst Price Target
BPMC's average price target has moved up $1.69 over the prior 175 days.
BPMC reports an average of 24.16% for its upside potential over the past 14 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-15 | 13 | 152 | 81 | 119.69 | 81.28 | 47.26% |
| 2021-06-11 | 13 | 152 | 81 | 117.92 | 86.90 | 35.7% |
| 2021-04-22 | 13 | 152 | 81 | 117.62 | 94.40 | 24.6% |
| 2021-03-18 | 13 | 152 | 81 | 117.08 | 98.79 | 18.51% |
| 2021-01-21 | 14 | 152 | 81 | 118.00 | 99.86 | 18.17% |
| 2020-10-30 | 14 | 146 | 81 | 114.93 | 102.28 | 12.37% |
| 2020-10-30 | 14 | 150 | 81 | 113.00 | 102.28 | 10.48% |
| 2020-09-27 | 14 | 121 | 77 | 102.00 | 88.00 | 15.91% |
| 2020-09-22 | 14 | 121 | 77 | 102.00 | 87.27 | 16.88% |
| 2020-09-07 | 14 | 110 | 77 | 97.93 | 73.04 | 34.08% |
| 2020-07-30 | 14 | 110 | 76 | 97.36 | 73.89 | 31.76% |
| 2020-07-21 | 14 | 110 | 76 | 97.00 | NA | NA% |
| 2020-07-14 | 15 | 110 | 76 | 96.87 | NA | NA% |
| 2020-07-11 | 15 | 111 | 59 | 90.07 | NA | NA% |
| 2020-06-05 | 15 | 111 | 59 | 90.07 | NA | NA% |
BPMC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.43 | 6 | 4 | 4 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 15 months, BPMC's average broker recommendation rating worsened by 0.66.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BPMC has a greater average analyst price target than 94.15% of Pharmaceutical Products stocks.
- The number of analysts covering the stock of BPMC is higher than 91.16% of Pharmaceutical Products stocks.
- Blueprint Medicines Corp's variance in analysts' estimates is less than 17.33% of all US stocks.
- BPMC has a greater upside potential (average analyst target price relative to current price) than 81.78% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, FATE, HZNP and RARE are the three stocks most similar to Blueprint Medicines Corp regarding the price target and analyst recommendation information presented here.
What is the outlook for BPMC? Use POWR Ratings for clearer insight into price direction.